Conference on Retroviruses & Opportunistic Infections

7-4-2018As we pause for the 4th of July holiday, we thought it was a good opportunity to look back at the posts that were of particular interest to our readers this yea…

3-28-2018Earlier this month, we partnered with Federal colleagues from NIH, CDC, and HRSA to share highlights of and perspectives on HIV research coming out of the 2018 …

3-9-2018As we prepare to observe National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) on March 10, we wanted to share this video of our recent conversation with NI…

3-8-2018Our coverage from the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston wrapped up yesterday with two interviews with Federal HIV le…

3-7-2018Our coverage from the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston continued yesterday with three interviews with Federal HIV l…

3-6-2018Nearly 90 percent of participants in an open-label study of a vaginal ring infused with a drug to prevent HIV are using the monthly ring at least some of the ti…

3-6-2018A new CDC analysis suggests that only a small percentage of Americans who could benefit from pre-exposure prophylaxis (PrEP), a daily pill for HIV prevention, h…

3-6-2018Advances in HIV research are being shared this week at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, and HIV.gov is here sh…

3-5-2018A one-month antibiotic regimen to prevent active tuberculosis (TB) disease was at least as safe and effective as the standard nine-month therapy for people livi…

3-5-2018A woman’s risk of acquiring HIV through sex with a male partner living with HIV increases during pregnancy and is highest during the postpartum period, ne…